PharmTech spoke with Dr. Hui-Yin (Harry) Li, president and CEO of Wilmington PharmaTech, about steps that should be taken to build a productive relationship between sponsor and contract organizations.
Dr. Hui-Yin (Harry) Li
Advertisement
Dr. Hui-Yin (Harry) Li is president and CEO of Wilmington PharmaTech.
Articles by Dr. Hui-Yin (Harry) Li
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
H1 2026 in Review: AI Adoption, Onshoring, and Data Gaps
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
Regulatory Roundup—July 2026
5